Rapid Micro Biosystems, Inc.

RPID

NASDAQ

Healthcare

Medical - Devices

Lowell, MA, US163 employeesrapidmicrobio.com

$2.27

+0.10(4.86%)

Mkt Cap $103M

$1.98

$4.68

52-Week Range

At a Glance

AI-generated

Rapid Micro Biosystems, Inc.

Revenue breakdown: Product (68.4%), Service (31.6%).

8-K

Rapid Micro Biosystems, Inc. issued a press release on March 12, 2026, announcing its financial results and a new multi-system order from Samsung Biologics for its Growth Direct system. The disclosures cover results of operations and Regulation FD information via Exhibit 99.1.

$103M

Market Cap

$34M

Revenue

-$48M

Net Income

Employees163

Fundamentals

How The Business Makes Money

Revenue by Segment

Product68.4%($42M)

Service31.6%($19M)

Revenue by Geography

US39.1%($24M)

All Other Countries20.1%($12M)

CH19%($12M)

DE14.3%($9M)

JP7.5%($5M)

Activity

What Changed Recently

Financial Results

Mar 11, 2026

Results of Operations and Financial Condition. On March 12, 2026, Rapid Micro Biosystems, Inc. (the “Company”) issued a press release announcing its financial r

Financial Results

Jan 12, 2026

, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchan

Peer Companies

Company	Price	Change	Market Cap	P/E
APYXApyx Medical Corporation	$3.67	+0.96%	$153M	-15.0
LUCDLucid Diagnostics Inc.	$1.15	-0.43%	$117M	-2.5
OWLTOwlet, Inc.	$5.12	+0.49%	$93M	-78.3
RCELAVITA Medical, Inc.	$3.69	-2.25%	$92M	-2.5
SERASera Prognostics, Inc.	$2.00	-3.38%	$76M	-2.8
LNSRLENSAR, Inc.	$6.01	+0.67%	$72M	-1.4
NSPRInspireMD, Inc.	$1.51	-3.82%	$71M	-2.6
CGTXCognition Therapeutics, I...	$0.88	-1.84%	$64M	-3.1

Analyst View

Company Profile

CIK0001380106

ISINUS75340L1044

CUSIP75340L104

Phone978 349 3200

Address1001 Pawtucket Boulevard West, Lowell, MA, 01854, US

SEC EDGAR